RIL
MYGN icon

Rothschild Investment LLC’s Myriad Genetics MYGN Stock Holding History

Rothschild Investment LLC’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.09K Buy
716
+379
+112% +$1.72K ﹤0.01% 2397
2026
Q1 		$1.52K Buy
337
+66
+24% +$344 ﹤0.01% 2679
2025
Q4 		$1.67K Buy
271
+47
+21% +$341 ﹤0.01% 2462
2025
Q3 		$1.62K Buy
+224
New +$1.33K ﹤0.01% 2358
2025
Q2 		– Sell
-105
Closed -$931 – 3130
2025
Q1 		$931 Buy
105
+75
+250% +$901 ﹤0.01% 2381
2024
Q4 		$411 Sell
30
-60
-67% -$1.11K ﹤0.01% 2607
2024
Q3 		$2.46K Buy
90
+55
+157% +$1.49K ﹤0.01% 1619
2024
Q2 		$856 Buy
35
+25
+250% +$549 ﹤0.01% 1742
2024
Q1 		$213 Buy
+10
New +$215 ﹤0.01% 1720

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rothschild Investment LLC's MYGN Position: Q2 2026 in Review

Rothschild Investment LLC increased its Myriad Genetics (MYGN) stake by 112% in Q2 2026, buying an estimated $1.72K and bringing the position to 716 shares worth $4.09K. The position accounts for ﹤0.01% of the portfolio, ranked #2397.

Rothschild Investment LLC first reported a position in MYGN in Q1 2024 and has held it in 9 quarters since. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Rothschild Investment LLC held 716 shares of Myriad Genetics worth $4.09K as of Q2 2026.
  • Rothschild Investment LLC bought 379 Myriad Genetics shares in Q2 2026, an estimated $1.72K.
  • Myriad Genetics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2397 holding.
  • Rothschild Investment LLC first reported a position in Myriad Genetics in Q1 2024 and has held it in 9 quarters since.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.